Claude Maraoui, the President & CEO of $DERM, sold 49,271 shares of the company on 03-11-2025 for an estimated $246,847. We received data on the trade from a recent SEC filing. This was a sale of approximately 2.4% of their shares of this class of stock. Following this trade, they now own 2,003,147 shares of this class of $DERM stock.
$DERM Insider Trading Activity
$DERM insiders have traded $DERM stock on the open market 7 times in the past 6 months. Of those trades, 0 have been purchases and 7 have been sales.
Here’s a breakdown of recent trading of $DERM stock by insiders over the last 6 months:
- CLAUDE MARAOUI (President & CEO) has made 0 purchases and 6 sales selling 160,283 shares for an estimated $811,060.
- JOSEPH BENESCH (CFO) sold 1,365 shares for an estimated $7,084
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$DERM Hedge Fund Activity
We have seen 18 institutional investors add shares of $DERM stock to their portfolio, and 19 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- TANG CAPITAL MANAGEMENT LLC added 1,725,569 shares (+inf%) to their portfolio in Q4 2024, for an estimated $6,746,974
- ROSALIND ADVISORS, INC. removed 105,917 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $414,135
- CITADEL ADVISORS LLC added 44,568 shares (+inf%) to their portfolio in Q4 2024, for an estimated $174,260
- NEUBERGER BERMAN GROUP LLC removed 35,899 shares (-55.7%) from their portfolio in Q4 2024, for an estimated $140,365
- RENAISSANCE TECHNOLOGIES LLC removed 32,200 shares (-12.0%) from their portfolio in Q4 2024, for an estimated $125,902
- ACADIAN ASSET MANAGEMENT LLC removed 24,353 shares (-58.4%) from their portfolio in Q4 2024, for an estimated $95,220
- WALLEYE CAPITAL LLC removed 23,098 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $90,313
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
